Screener
Eton Pharmaceuticals, Inc. ETON Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $13,485 | $10,976 |
| Short-term debt, net of debt discount | 11,808 | 8,789 |
| Accrued Medicaid rebates | 11,140 | 9,317 |
| Accrued liabilities | 7,746 | 9,408 |
| Total current liabilities | 44,179 | 38,490 |
| Long-term debt, net of current portion and debt discount | 18,939 | 21,769 |
| Operating lease liabilities, net of current portion | 440 | 460 |
| Other long-term liabilities | 3,537 | 5,241 |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s accrued expenses?
- Eton Pharmaceuticals, Inc. (ETON) reported accrued expenses of $7.75M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s accrued expenses changed year-over-year?
- Eton Pharmaceuticals, Inc.'s accrued expenses increased by 2.7% year-over-year, from $7.54M to $7.75M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s accrued expenses has grown at a 88.4% compound annual growth rate (CAGR), from $396K to $9.41M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Eton Pharmaceuticals, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude